CRISPR/Cas9-mediated Homologous Recombination in Human iPSCs to Correct MYO7A Heterozygous Point Mutation Is Determined by&nbsp;Double-strand Break Targeting Sites

doi:10.13865/j.cnki.cjbmb.2019.09.08

CRISPR/Cas9-mediated Homologous Recombination in Human iPSCs to Correct MYO7A Heterozygous Point Mutation Is Determined by Double-strand Break Targeting Sites

TANG Zi-Hua, CHEN Jia-Rong, DING Jie, CHEN Jian-Ling, WANG Cui-Cui, WANG Jin-Fu

Chinese Journal of Biochemistry and Molecular Biology ›› 2019, Vol. 35 ›› Issue (9) : 975-985.

PDF(17900 KB)

Chinese Journal of Biochemistry and Molecular Biology ›› 2019, Vol. 35 ›› Issue (9) : 975-985. DOI: 10.13865/j.cnki.cjbmb.2019.09.08

CRISPR/Cas9-mediated Homologous Recombination in Human iPSCs to Correct MYO7A Heterozygous Point Mutation Is Determined by Double-strand Break Targeting Sites

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2019, 35(9): 975-985 https://doi.org/10.13865/j.cnki.cjbmb.2019.09.08

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(17900 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Revised	Published
2019-05-13	2019-07-07	2019-09-20
Issue Date
2019-09-20

Please choose a citation manager

Content to export